Endpoints News 2026-02-22 MoonLake has 'confidence' ahead of FDA submission, discloses mid-stage arthritis win
Endpoints News 2026-02-21 Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more